Population‐based patterns of human immunodeficiency virus‐related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998
Open Access
- 2 July 2003
- Vol. 98 (2) , 300-309
- https://doi.org/10.1002/cncr.11459
Abstract
BACKGROUND: Epidemiologic characteristics of human immunodeficiency virus (HIV)‐related Hodgkin lymphoma (HL) have not been examined in the Greater San Francisco Bay Area, a center of the HIV/acquired immunodeficiency syndrome (AIDS) epidemic, for a decade, despite changes in AIDS‐associated diseases after the availability of highly active antiretroviral therapies (HAART).METHODS: With population‐based cancer registry data for 1988–1998, the authors examined risk factors, Epstein–Barr virus (EBV) association, incidence rates, and survival probabilities for 1752 patients with HL who were classified as HIV‐positive or HIV‐negative by a cancer registry‐based method.RESULTS: One hundred twenty‐eight patients with HL (7%) were classified with HIV/AIDS; 95% were male. Among males, multivariate analysis (n = 514 patients) found that HIV‐related HL was associated strongly at diagnosis with ages 30–49 years, San Francisco residence, late‐stage disease, lymphocyte depletion and unspecified histologic subtypes, and tumor cell EBV but not with other clinical features or mixed cellularity histology. Survival among patients with HIV‐related HL, although it was poor, did not differ by race/ethnicity but was worse for patients with the nonnodular sclerosis histologic subtypes. Patients who were HIV‐positive with HAART era (1996–1998) diagnoses were slightly older, were less likely to live in San Francisco, and were much more likely to be Hispanic compared with HIV‐positive patients who were diagnosed before the HAART era; they had somewhat less aggressive disease and better survival. Incidence rates were higher for patients with HL overall compared with patients who had HIV‐unrelated HL by 11% for white patients, 22% for black patients, and by 14% for Hispanic patients; excesses were greater in young adults.CONCLUSIONS: Among males in the San Francisco Bay Area, HIV‐related HL had distinctive demographic features, more aggressive clinical characteristics, stronger EBV association, and poorer survival and contributed to elevated regional HL incidence rates, particularly in young adults. Patients with HIV‐related HL who were diagnosed after HAART was introduced appeared to have less aggressive disease and better survival. Cancer 2003;98:300–9. © 2003 American Cancer Society.DOI 10.1002/cncr.11459Keywords
This publication has 38 references indexed in Scilit:
- Hodgkin's disease etiology and novel viruses: Clues from groups exposed to blood productsInternational Journal of Cancer, 2003
- Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapyAIDS, 2003
- AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patientsEuropean Journal of Internal Medicine, 2002
- Guidelines for Interpreting EBER In Situ Hybridization and LMP1 Immunohistochemical Tests for Detecting Epstein-Barr Virus in Hodgkin LymphomaAmerican Journal of Clinical Pathology, 2002
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesisLeukemia, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Human Immunodeficiency Virus Associated Hodgkin's Disease: Report of 45 Cases from the French Registry of HIV-Associated TumorsLeukemia & Lymphoma, 1995
- High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large‐cell ki‐1‐positive lymphomas in HIV‐1‐positive patientsInternational Journal of Cancer, 1993
- Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates.American Journal of Public Health, 1992